Heart failure is a common clinical syndrome associated with significant morbidity and
mortality worldwide. Ischemic heart disease is the leading cause of heart failure, at least in …

Heart failure is a serious condition with poor prognosis, which imposes an ever increasing
burden on healthcare systems due to its rising prevalence. Nonetheless, physiological …

Congestive heart failure (CHF) has become a large social burden in modern Western
society, with very high morbidity and mortality and extremely large financial costs. The …

In the last two decades, the field of nuclear cardiology has experienced significant progress.
The introduction of positron emission tomography (PET) imaging represented a major …

There has been considerable improvement in the morbidity and mortality from
cardiovascular disease over the past few decades. Along with the advancements in …

In this article, the role of nuclear medicine modalities in assessing myocardial viability and
risk stratification in patients with advanced left ventricular (LV) dysfunction are reviewed …

Positron emission tomography (PET) myocardial perfusion imaging is being increasingly
used for the detection of coronary artery disease. In the presence of significant left ventricle …

Cardiac positron emission tomography (PET) and positron emission tomography/computed
tomography (PET/CT) are encouraging precise non-invasive imaging modalities that allow …

Current American Heart Association/American College of Cardiology practice guidelines
classify congestive heart failure (CHF) in 4 stages (A, B, C, and D). This review focuses on …

Myocardial viability assessment is of utmost importance in the assessment of patients with
poor left ventricular function undergoing revascularisation therapies or cardiac …